Recent

% | $
Quotes you view appear here for quick access.

Pfizer Inc. Message Board

  • fizrwinnr11 fizrwinnr11 Jun 3, 2013 9:19 AM Flag

    How the big pharmas are performing

    01) Up 41.3%. BMY (#10 in 2012, #01 in 2011 and #02 in 2010). #01 last week
    02) Up 21.2%. ABT (#03 in 2012, #04 in 2011 and #09 in 2010). #02 last week
    03) Up 20.1%. GSK (#09 in 2012, #05 in 2011 and #08 in 2010) #04 last week
    04) Up 20.1%. JNJ (#07 in 2012, #07 in 2011 and #07 in 2010). #03 last week
    05) Up 14.1%. MRK (#06 in 2012, #08 in 2011 and #03 in 2010). #08 last week
    06) Up 12.0%. SNY (#01 in 2012, #06 in 2011 and #10 in 2010). #07 last week
    07) Up 11.8%. NVS (#05 in 2012, #10 in 2011 and #01 in 2010). #05 last week
    08) Up 09.8%. LLY (#02 in 2012, #03 in 2011 and #05 in 2010). #10 last week
    09) Up 08.6%. PFE (#04 in 2012, #02 in 2011 and #06 in 2010). #06 last week
    10) Up 08.4%. AZN (#08 in 2012, #09 in 2011 and #04 in 2010). #09 last week

    Up 16.7%. Avg. of the ten big pharmas
    Up 17.7%. Avg. of PFE's nine big peers
    Up 19.2%. Avg. of the six domestic pharmas
    Up 20.3%. Avg. of PFE's five domestic peers
    Up 13.1%. Avg. of the four European pharmas

    Up 14.4%. S & P 500 (1,326 to 1,631)

    Note: ABT includes ABBV

    Note: This is PFE's lowest weekly ranking in 23 months

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • good post. the piplines going forward need to be evaluated. I see NVS a pick as the population ages. Not sure in comparison why and certainly not advocating NVS. PFE a dissapointment hopfully short term. I sold USB and XLF thinking PFE a better investment but I was wrong. I also believe all CEOs are ready at the layoff button if balance sheets go red, at PFE perhaps staying the course weighed in. Bought at 19.

 
PFE
33.37-0.32(-0.95%)Jul 2 4:02 PMEDT